The Acton, Mass.-based facility is set to turn to the new energy source, beginning this week. The company covered its 58,000 square-foot manufacturing facility with approximately 2,800 solar panels to, during optimal climate conditions, generate enough energy to fully support the corporate headquarters and manufacturing facility.
Insulet began the installation of the solar panels in January and received approval for turning on the system from the town of Acton earlier this week, according to a news release.
The wearable insulin delivery system developer’s installation has an energy capacity of 900 kilowatts, which can power 30 average-sized U.S. homes daily. Insulet’s 2020 sustainability report highlighted its intention to reduce its carbon footprint and foster a sustainable business.
“We understand our responsibility to help protect the environment and this is another important step toward reducing our carbon footprint,” Insulet executive VP & COO Chuck Alpuche said in the release. “We are continuously looking to establish and enhance our environmentally and socially responsible best practices as we improve our sustainability measures and focus on our long-term goals.”
